https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/3D-Brain.jpg8001200Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2026-01-09 08:00:502026-08-14 12:48:43NRG doses first volunteers in mitochondrial ALS trial
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/DDW-new-advisor-from-MJFF-banner.jpg8191238Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-12-02 08:01:172026-08-14 13:36:04Michael J Fox Foundation adviser joins NRG Therapeutics
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/thepharmaletter-banner.webp8191238Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-12-02 08:00:352026-08-14 12:54:04NRG Therapeutics expands team with CDO appointment
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/DDW-new-appointment-banner.jpg8191238Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-12-01 08:00:342026-08-14 12:55:39NRG Therapeutics appoints Paul Thompson as CDO
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/pwc-banner.jpg8191238Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-11-30 08:00:592026-09-09 17:39:23UK Life Sciences Future50 – Momentum in an evolving landscape
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/labiotech-25Nov25-banner.jpg8441500Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-11-25 08:00:512026-08-14 12:58:4011 neuroscience biotech companies you should know about
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/Longevity-News-image.jpg8191238Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-10-09 08:00:562026-08-14 13:17:25Is this mitochondria’s big moment?
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/BIA-banner.jpg8191238Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-10-08 08:00:342026-08-14 13:18:35Biotechs, BIA, patient charities and investors: the power of relationships
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/NRG-emerging-company-profile-1-oct25.jpg10001500Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-10-01 08:00:162026-09-09 17:38:56NRG Therapeutics: Restoring motor neuron function via mitochondria
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/NRG-Therapeutics-ounding-team-in-lab.jpg10001500Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-09-08 08:05:422026-09-09 17:39:46NRG raises $67M to test mitochondrial pore inhibitor in ALS
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/Neil_Miller_CEO_NRG_Therapeutics_-_in_lab.webp9001600Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-09-08 08:04:132026-08-14 13:52:49A UK biotech takes aim at Parkinson’s, ALS by drugging mitochondria
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/AXKEEI4DDZEXNHXPEMIEQBLT54_2.jpg8441500Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2025-09-08 08:03:052026-09-09 17:40:02UK’s NRG Powers Up With £50m For Promising Mitochondrial Therapy
NRG doses first volunteers in mitochondrial ALS trial
Longevity Technology
Read more
Michael J Fox Foundation adviser joins NRG Therapeutics
Business Weekly
Read more
NRG Therapeutics expands team with CDO appointment
thepharmaletter
Read more
NRG Therapeutics appoints Paul Thompson as CDO
Drug Discovery World
Read more
UK Life Sciences Future50 – Momentum in an evolving landscape
pwc
Read more
(pdf)
11 neuroscience biotech companies you should know about
Labiotech
Read more
Is this mitochondria’s big moment?
Longevity Technology
Read more
Biotechs, BIA, patient charities and investors: the power of relationships
BIA, UK BioIndustry Association
Read more
NRG Therapeutics: Restoring motor neuron function via mitochondria
BioCentury
Read more
(behind a paywall)
NRG raises $67M to test mitochondrial pore inhibitor in ALS
BioWorld
Read more
(behind a paywall)
A UK biotech takes aim at Parkinson’s, ALS by drugging mitochondria
Biopharma Dive
Read more
UK’s NRG Powers Up With £50m For Promising Mitochondrial Therapy
SCRIP
Read more
(behind a paywall)